![]() |
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
|||||||||
Glaucoma is a chronic medical condition. You should work with your eye care professional and his or her staff to get the information you need for successful treatment. Don’t hesitate to ask questions. As a patient, the decisions you make and the actions you take to treat your condition make you an integral part of your eye care therapy. Questions to ask your eye care professional
|
|
ALPHAGAN® P ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Important Safety Information ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% should not be used in patients receiving monoamine oxidase (MAO) inhibitor therapy. Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, ocular redness, and itching. Adverse events occurring in approximately 5% to 9% included: burning sensation, increased ocular lymph nodules, increased ocular pressure, ocular allergic reaction, dry mouth, and blurred vision. Please click here for full Prescribing Information. |



